Taylor, Susan
Korman, Neil J.
Tsai, Tsen-Fang
Shimomura, Yutaka
Feely, Meghan
Dutronc, Yves
Wu, Wen-Shuo
Somani, Najwa
Tosti, Antonella
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 17 May 2023
Accepted: 8 September 2023
First Online: 23 September 2023
Change Date: 17 November 2023
Change Type: Update
Change Details: “Article note updated”.
Declarations
:
: Susan Taylor is an employee and is on the board of directors of Mercer Strategies. Susan Taylor is also a speaker for Beiersdorf, Inc., Evolus, Inc, MJH LifeSciences, and L'Oréal USA. Susan Taylor is on the advisory board for Beiersdorf, Inc., Biorez, Inc., Galderma Laboratories, L.P., GloGetter, Hugel America, Inc., Janssen, L'Oréal USA, Medscape/WebMD, Scientis US, and UCB. Susan Taylor is a consultant for Arcutis Biotherapeutics, Inc., Armis Scientific, Beiersdorf, Inc., Cara Therapeutics, Cara Therapeutics, Evolus, Inc., Johnson & Johnson Consumer Products Company, Piction Health, Regeneron, Vichy Laboratoires. Susan Taylor is an author for McGraw-Hill, and is on the editorial board for Practical Dermatology, Cutis, and Archives in Dermatologic Research. ST is also a peer reviewer for the British Journal of Dermatology and an investigator for Concert Pharmaceuticals, Croma-Pharma, Eli Lilly, and Pfizer. Neil J. Korman reported receiving grants and personal fees from AbbVie, Eli Lilly, Leo Pharma, Principia, and Trevi; grants from Amgen, Celgene, Chemocentryx, Dermira, Menlo Therapeutics, Syntimmune, and XBiotech; and personal fees from Genentech, Janssen, Novartis, Regeneron, Sun Pharma, and UCB. Tsen-Fang Tsai has conducted clinical trials or received honoraria for serving as a consultant for AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly, Galderma, GSK-Stiefel, Janssen-Cilag, Leo Pharma, Merck, Novartis, Pfizer Inc., and UCB Pharma. Yukata Shimomura receives advisory fees from Eli Lilly Japan K.K. and Maruho Co. YS also receives research grants for studies not related to this work from Eli Lilly Japan K.K., Maruho Co., and Sun Pharma Japan Ltd. Meghan Feely is an associate staff member at: Mount Sinai Hospital; is a current employee and shareholder of: Eli Lilly and Company; has received consulting, travel, or speaker fees from: American Academy of Dermatology, Aerolase, Castle Biosciences, CeraVe—L'Oréal, DREAM USA, Galderma Aesthetics, Glow Recipe, La Roche-Posay—L'Oréal, Revian, Sonoma Pharmaceuticals, Sun Pharma, and Suneva Medical. Yves Dutronc, Wen-Shuo Wu, and Najwa Somani are employees, and shareholders of Eli Lilly and Company. Antonella Tosti is a compensated consultant/advisory board member for Eli Lilly, the sponsor of the study. Antonella Tosti is also a consultant for DS Laboratories, Monat Global, Almirall, Tirthy Madison, P&G, Pfizer, Myovant, Bristol Myers Squibb, Curallux LLC, and PI for Eli Lilly, Concert, and Erconia.
: The trials were conducted in accordance with ethical principles of the Declaration of Helsinki and Good Clinical Practice guidelines, and the research protocols were approved by each center’s institutional review board or ethics committee. All patients provided written informed consent.